Unlock instant, AI-driven research and patent intelligence for your innovation.

Improved continuous microparticle manufacture

A technology of microparticles and liquid dispersions, which is used in medical preparations containing active ingredients, drug combinations, organic active ingredients, etc., and can solve the problems of low drug loading of microparticles, insufficient control of drug release curves, and particle instability. The effect of achieving high drug loading levels, reducing residence time, and reducing the incidence of leaching

Inactive Publication Date: 2021-01-15
GRAYBUG VISION INC
View PDF15 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Despite these advances, these approaches often result in microparticles that (i) have low drug loading, (ii) have particle instability, and / or (iii) have insufficient control over the drug release profile

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Improved continuous microparticle manufacture
  • Improved continuous microparticle manufacture
  • Improved continuous microparticle manufacture

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0312] Example 1: Synthesis of risperidone-containing microparticles using a plug flow reactor and TWHFTFF

[0313]By mixing 180 mg / mL poly(lactic-co-glycolic acid) (PLGA) / monomethoxypolyethylene glycol-PLGA (mPEG) (99:1 mixture) in dichloromethane (DCM) in a dispersion phase tank The dispersed phase was prepared with a solution of 50.1 mg / mL risperidone in dimethyl sulfoxide (DMSO) until a homogeneous solution was obtained. The continuous phase was prepared from 0.25% PVA and water in a continuous phase tank. The dispersed and continuous phases are fed into the in-line mixer through their respective conduits. The dispersed phase was passed through a hydrophobic PTFE filter and fed into an inline mixer via a cannula at a rate of 20 mL / min. The continuous phase was passed through a hydrophilic PVDF filter (0.20 μιη) and fed into an inline mixer at a rate of 2000 mL / min via a cannula. An impeller rotating at 4000 rpm in the in-line mixer provided thorough mixing of the disper...

Embodiment 2

[0314] Example 2: Synthesis of risperidone-containing microparticles using continuous centrifugation

[0315] By mixing 180 mg / mL poly(lactic-co-glycolic acid) (PLGA) / monomethoxypolyethylene glycol-PLGA (mPEG) (99:1 mixture) in dichloromethane (DCM) in a dispersion phase tank The dispersed phase was prepared with a solution of 50.1 mg / mL risperidone in dimethyl sulfoxide (DMSO) until a homogeneous solution was obtained. The continuous phase was prepared from 0.25% PVA and water in a continuous phase tank. The dispersed and continuous phases are fed into the in-line mixer through their respective conduits. The dispersed phase was passed through a hydrophobic PTFE filter and fed into an inline mixer via a cannula at a rate of 20 mL / min. The continuous phase was passed through a hydrophilic PVDF filter (0.20 μιη) and fed into an inline mixer at a rate of 2000 mL / min via a cannula. An impeller rotating at 4000 rpm in the in-line mixer provided thorough mixing of the dispersed a...

Embodiment 3

[0316] Example 3: Continuous centrifugation as a separation process to remove small particles

[0317] Continuous centrifugation is introduced as a separation process in the production of surface-treated particles (STP) in order to remove small particles and to wash and concentrate the particles. The process continuously separates small particles from larger particles by centrifugation and discharges the retained larger particles at the end of the cycle. Serial centrifugation was performed using a UniFuge Pilot separation system from Pneumatic Scale Angelus. Figure 1M and Figure 1N Centrifuge 1, Centrifuge 2, Centrifuge 3 and Centrifuge 4 are involved.

[0318] For batches of 200g scale, centrifuge 1 was performed simultaneously with the homogenization step for approximately 2 hours: as the dispersed phase (DP) and continuous phase (CP) were mixed in the homogenizer, the resulting liquid from the homogenizer flowed into into a glass container. The volume of the container...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
sizeaaaaaaaaaa
sizeaaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The present invention is in the field of manufacturing drug-loaded microparticles, and specifically provides processes for producing approximately homogenously sized drug loaded microparticles with high drug loading and reproducible drug release profiles, and which may be provided in a significantly reduced time period.

Description

[0001] Cross References to Related Applications [0002] This application claims the benefit of Provisional U.S. Application No. 62 / 661,561, filed April 23, 2018, U.S. Application No. 62 / 661,563, filed April 23, 2018, and U.S. Application No. 62 / 661,566, filed April 23, 2018 . The entire content of each of these applications is incorporated herein by reference. technical field [0003] The present invention belongs to the field of manufacture of drug-loaded microparticles, and in particular provides methods for producing drug-loaded microparticles of approximately uniform size with high drug loading and reproducible drug release profiles, and which can be produced in a significantly reduced provided in the section. Background technique [0004] Biodegradable polymers offer a well-established route for drug delivery in a controlled and targeted manner. Bulk release of encapsulated drug molecules from biodegradable polymers is achieved through degradation and erosion of th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C08F6/14
CPCC08F6/14A61P35/00A61K31/519A61K9/1647A61K9/1694A61K31/404A61K9/1629A61K9/1682
Inventor D·萨拉格内塞杨明余韵T-R·吉里巴D·麦肯齐
Owner GRAYBUG VISION INC